DAWN : Insider Transactions for Day One Biopharmaceuticals, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Day One Biopharmaceuticals, Inc. (DAWN)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

87,040,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	2,244,684	4,978,018
Total Buy Value	$0	$0	$24,978,318	$65,978,328
Total People Bought	0	0	1	3
Total Buy Transactions	0	0	4	7
Total Shares Sold	225,453	235,538	246,104	4,525,329
Total Sell Value	$3,837,225	$3,955,119	$4,100,690	$62,122,635
Total People Sold	4	4	4	8
Total Sell Transactions	14	18	25	103
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 174

Page 5 of 7

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Canaan Partners Xi Llc

10% Owner

– – •

2022-09-16

4

S

$21.53

$2,484,458

D/D

(115,307)

9,303,299

-

Canaan Partners Xi Llc

10% Owner

– – •

2022-09-15

4

S

$22.79

$1,171,809

D/D

(51,281)

9,418,606

-

Director

– • –

2022-09-15

4

S

$22.79

$1,171,809

I/I

(51,281)

9,418,606

-

Canaan Partners Xi Llc

10% Owner

– – •

2022-09-14

4

S

$23.68

$2,512,943

D/D

(106,111)

9,469,887

-

Director

– • –

2022-09-14

4

S

$23.68

$2,512,943

I/I

(106,111)

9,469,887

-

Canaan Partners Xi Llc

10% Owner

– – •

2022-09-13

4

S

$24.39

$2,138,332

D/D

(87,647)

9,575,998

-

Director

– • –

2022-09-13

4

S

$24.39

$2,138,332

I/I

(87,647)

9,575,998

-

Director

– • –

2022-09-02

4

AS

$23.82

$119,108

I/I

(5,000)

439,358

-

Director

– • –

2022-09-01

4

AS

$23.21

$116,358

I/I

(5,000)

444,358

-

York Charles N Ii

COO, CFO and Secretary

• – –

2022-09-01

4

AS

$23.16

$232,484

D/D

(10,000)

314,401

-

Blackman Samuel C.

Chief Medical Officer

• – –

2022-09-01

4

AS

$23.14

$232,452

D/D

(10,000)

1,289,338

-

Chief Executive Officer

• • –

2022-09-01

4

AS

$23.15

$290,581

D/D

(12,500)

1,240,375

-

York Charles N Ii

COO, CFO and Secretary

• – –

2022-08-16

4

S

$24.31

$26,474

D/D

(1,089)

324,401

-

Blackman Samuel C.

Chief Medical Officer

• – –

2022-08-16

4

S

$24.31

$22,876

D/D

(941)

1,299,338

-

Chief Executive Officer

• • –

2022-08-16

4

S

$24.31

$97,313

D/D

(4,003)

1,252,875

-

York Charles N Ii

COO, CFO and Secretary

• – –

2022-08-15

4

OE

$0.00

$0

D/D

4,125

325,490

-

Blackman Samuel C.

Chief Medical Officer

• – –

2022-08-15

4

OE

$0.00

$0

D/D

3,561

1,300,279

-

Chief Executive Officer

• • –

2022-08-15

4

OE

$0.00

$0

D/D

10,686

1,256,878

-

Director

– • –

2022-08-05

4

AS

$20.00

$100,000

I/I

(5,000)

449,358

-

Director

– • –

2022-08-04

4

AS

$20.00

$100,004

I/I

(5,000)

454,358

-

York Charles N Ii

COO, CFO and Secretary

• – –

2022-08-04

4

AS

$20.05

$200,541

D/D

(10,000)

321,365

-

Chief Executive Officer

• • –

2022-08-04

4

AS

$20.00

$250,021

D/D

(12,500)

1,246,192

-

Blackman Samuel C.

Chief Medical Officer

• – –

2022-08-01

4

AS

$16.88

$168,810

D/D

(10,000)

1,296,718

-

Director

– • –

2022-07-18

4

AS

$20.00

$52,001

I/I

(2,600)

459,358

-

York Charles N Ii

COO, CFO and Secretary

• – –

2022-07-18

4

AS

$20.00

$50,000

D/D

(2,500)

331,365

-

174 Records found	1 2 3 4 5 6 7	Page 5 of 7

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.